查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
疫苗佐劑市場，按產品類型、按應用、按使用類型、按疾病領域、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419053

疫苗佐劑市場，按產品類型、按應用、按使用類型、按疾病領域、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Vaccine Adjuvants Market, By Product Type, By Application, By Usage Type, By Disease Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年疫苗佐劑市場規模為 7.125 億美元，2023 年至 2030 年複合CAGR為 7.2%。

疫苗佐劑市場-市場動態

傳染病發生率上升推動市場需求

流感、結核病、霍亂、小兒麻痺、麻疹、瘧疾和愛滋病毒等傳染病的盛行率不斷上升。據世界衛生組織稱，結核病是全球第13 大死亡原因，並在2021 年成為僅次於COVID-19 的第二大傳染病死亡原因，全球報告死亡人數近160 萬人，其中包括187,000 名愛滋病毒感染者。病例激增給疫苗生產帶來了巨大壓力，因為對抗此類傳染病所需的疫苗數量不斷增加，從而增加了對佐劑的需求。

疫苗佐劑市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 7.2% 左右的CAGR成長
  • 根據產品類型細分，預計助劑乳劑將在 2022 年顯示最大的市場佔有率
  • 從應用細分來看，2022年商用為主導類型
  • 根據使用類型細分，活性免疫增強劑是 2022 年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

疫苗佐劑市場-區隔分析：

全球疫苗佐劑市場根據產品類型、應用、使用類型、疾病領域和地區進行細分。

依產品類型，市場分為八類：礦物鹽佐劑、張力活性佐劑、乳液佐劑、脂質體佐劑、碳水化合物佐劑、細菌源佐劑、病毒樣顆粒（VLP）等。根據產品分類，預計佐劑乳劑細分市場將在預測期內保持領先地位。這主要歸因於傳染病患者病率的不斷上升，推動了疫苗中乳劑佐劑的使用，從而促進了這一特定領域的擴張。

市場依應用分為兩類：研究型和商業型。商業部門主導市場，並可能在預測期內保持其主導地位。隨著傳染病的增加和全球持續的公共衛生問題，對有效疫苗的需求日益成長。佐劑對開發提供更好保護的疫苗做出了重大貢獻，使醫療保健系統能夠擴大疫苗接種計劃，特別是在傳染病高發地區。

疫苗佐劑市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

疫苗佐劑市場-競爭格局：

疫苗佐劑市場目前正在經歷旨在提高疫苗功效和安全性的策略進步。這些創新集中在開創性的佐劑配方和輸送系統，旨在增強免疫反應，同時維護安全標準。大量的研究和開發工作旨在專門針對不同的疫苗客製化佐劑，從而增強其在不同人群中的有效性。此外，製藥公司、研究機構和監管機構之間的合作正在推動佐劑的開發和驗證，特別是針對新出現的傳染病和具有挑戰性的病原體。市場動態圍繞著監管遵守、成本效率和可擴展性，為加強疫苗反應並促進全球公共衛生改善的變革性佐劑技術奠定了基礎。

最近的發展：

2023 年1 月，專注於淋巴結靶向佐劑以及針對暴力癌症和傳染病的疫苗的Elicio Therapeutics 與Angion Biomedica Corp 敲定了一項聯盟協議。重點在於推進Elicio 獨特的淋巴結靶向Amphiphile 專業知識，以取得進展免疫療法，主要集中在 ELI-002，這是一種針對 mKRAS 驅動的腫瘤的治療性癌症疫苗。

2022年11月，Hubro Therapeutics AS透過資產購買協議從Targovax ASA收購了GM-CSF疫苗佐劑，涉及現金1,000萬挪威克朗。 Hubro 正在繼續開發 GM-CSF，作為其管道中一系列創新癌症疫苗的佐劑。

目錄

第1章：疫苗佐劑市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的疫苗佐劑市場片段
    • 疫苗佐劑市場片段（依應用）
    • 依使用類型分類的疫苗佐劑市場片段
    • 按疾病領域分類的疫苗佐劑市場片段
    • 按國家/地區分類的疫苗佐劑市場摘要
    • 按地區分類的疫苗佐劑市場片段
  • 競爭洞察

第 3 章：疫苗佐劑主要市場趨勢

  • 疫苗佐劑市場促進因素
    • 市場促進因素的影響分析
  • 疫苗佐劑市場限制
    • 市場限制影響分析
  • 疫苗佐劑市場機會
  • 疫苗佐劑市場未來趨勢

第 4 章：疫苗佐劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：疫苗佐劑市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：疫苗佐劑市場格局

  • 2022 年疫苗佐劑市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：疫苗佐劑市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 礦物鹽佐劑
    • 張力活性佐劑
    • 佐劑乳劑
    • 脂質體佐劑
    • 碳水化合物佐劑
    • 細菌來源的佐劑
    • 病毒樣顆粒 (VLP)
    • 其他

第 8 章：疫苗佐劑市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 研究應用
    • 商業應用

第 9 章：疫苗佐劑市場 - 依使用類型

  • 概述
    • 按使用類型分類的細分市場佔有率分析
    • 活性免疫增強劑
    • 營運商
    • 車用助劑

第 10 章：疫苗佐劑市場 - 按疾病領域

  • 概述
    • 按應用的細分市場佔有率分析
    • 傳染病
    • 癌症
    • 其他

第 11 章：疫苗佐劑市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美疫苗佐劑主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按使用類型）
    • 北美市場規模與預測（按疾病領域）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲疫苗佐劑主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按使用類型）
    • 歐洲市場規模與預測（按疾病領域）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區疫苗佐劑主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按使用類型）
    • 亞太地區市場規模與預測（按疾病領域）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗佐劑主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按使用類型）
    • 拉丁美洲市場規模與預測（按疾病領域）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲疫苗佐劑主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按使用類型）
    • 中東和非洲市場規模及預測（按疾病領域）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 疫苗佐劑產業

  • 競爭儀表板
  • 公司簡介
    • Associated British Foods Plc (spi Pharma Inc.)
    • Adjuvatis
    • Agenus Inc.
    • Aphios Corporation
    • Vertellus
    • Croda International PLC
    • CSL Limited
    • Dynavax Technologies Corporation
    • GlaxoSmithKline PLC
    • InvivoGen
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2118

REPORT HIGHLIGHT

Vaccine Adjuvants Market size was valued at USD 712.5 Million in 2022, expanding at a CAGR of 7.2% from 2023 to 2030.

Vaccine adjuvants are components integrated into vaccines to heighten the body's immune response triggered by the vaccine's antigen, which stimulates the immune system. These adjuvants function by amplifying the body's immune reaction, thereby enhancing the vaccine's effectiveness by bolstering the immune response and often permitting the use of smaller antigen amounts. They can induce a more robust and longer-lasting immune response, thereby elevating defense against the targeted disease. Adjuvants also aid in enhancing vaccine efficacy for specific populations, such as the elderly or individuals with compromised immune systems. Diverse adjuvant types encompass aluminum salts (like aluminum hydroxide or aluminum phosphate), oil-in-water emulsions (such as MF59 or AS03), toll-like receptor agonists, among others. Adjuvants are pivotal in vaccine development, facilitating the creation of more potent vaccines against various infectious diseases and augmenting overall vaccine effectiveness and the endurance of immune responses.

Vaccine Adjuvants Market- Market Dynamics

Increasing prevalence of infectious diseases to propel market demand

The prevalence of infectious diseases like influenza, tuberculosis, cholera, polio, measles, malaria, and HIV has escalated. According to the WHO, TB ranked as the 13th leading cause of death globally and stood as the second-leading infectious cause of death after COVID-19 in 2021, with almost 1.6 million reported deaths worldwide, including 187,000 individuals with HIV. The surge in cases has put immense pressure on vaccine production, as an increased number of vaccines are necessary to combat such contagious diseases, consequently heightening the demand for adjuvants.

Vaccine Adjuvants Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.2% over the forecast period (2023-2030)
  • Based on product type segmentation, adjuvant emulsions was predicted to show maximum market share in the year 2022
  • Based on application segmentation, commercial was the leading type in 2022
  • Based on Usage Type segmentation, Active Immunostimulants was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Vaccine Adjuvants Market- Segmentation Analysis:

The Global Vaccine Adjuvants Market is segmented on the basis of Product Type, Application, Usage Type, Disease Area, and Region.

The market is divided into eight categories based on product type: Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP) and Others. Based on product categorization, the adjuvant emulsions segment is forecasted to uphold its leading position during he forecat period. This is primarily accredited to the escalating prevalence of communicable diseases, propelling the usage of emulsion adjuvants in vaccines and consequently nurturing the expansion of this specific segment.

The market is divided into two categories based on application: research and commercial. The commercial sector dominates the market and is likely to maintain its dominance during the forecast period. With the rise in infectious diseases and ongoing public health concerns globally, there's a growing need for effective vaccines. Adjuvants contribute significantly to developing vaccines that offer improved protection, enabling healthcare systems to expand vaccination programs, especially in regions where there is a high prevalence of infectious diseases.

Vaccine Adjuvants Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Vaccine Adjuvants Market- Competitive Landscape:

The market for vaccine adjuvants is currently undergoing strategic advancements directed at enhancing both the efficacy and safety of vaccines. These innovations concentrate on pioneering adjuvant formulations and delivery systems, aiming to intensify immune responses while upholding safety standards. Significant research and development endeavors are directed towards tailoring adjuvants specifically for distinct vaccines, thereby augmenting their effectiveness across diverse demographic groups. Moreover, collaborations among pharmaceutical firms, research institutions, and regulatory bodies are propelling the development and validation of adjuvants, especially for emerging infectious diseases and challenging pathogens. Market dynamics center around regulatory adherence, cost-efficiency, and scalability, setting the stage for transformative adjuvant technologies that fortify vaccine responses and contribute to global public health improvements.

Recent Developments:

In January 2023, Elicio Therapeutics, specializing in lymph node-targeted adjuvants as well as vaccines for violent cancers along with infectious illnesses, finalized a union agreement with Angion Biomedica Corp. The focus lies on advancing Elicio's exclusive lymph node-targeting Amphiphile expertise to progress immunotherapies, primarily concentrating on ELI-002, a therapeutic cancer vaccine aimed at mKRAS-driven tumors.

In November 2022, Hubro Therapeutics AS acquired the GM-CSF vaccine adjuvant from Targovax ASA through an asset purchase agreement, involving a cash payment of NOK10 million. Hubro is continuing the development of GM-CSF as an adjuvant for its range of innovative cancer vaccines in its pipeline.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE ADJUVANTS MARKET KEY PLAYERS

  • Associated British Foods Plc (spi Pharma Inc.)
  • Adjuvatis
  • Agenus Inc.
  • Aphios Corporation
  • Vertellus
  • Croda International PLC
  • CSL Limited
  • Dynavax Technologies Corporation
  • GlaxoSmithKline PLC
  • InvivoGen
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE

  • Mineral Salt-based Adjuvant
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Liposome Adjuvants
  • Carbohydrate Adjuvants
  • Bacteria-derived Adjuvants
  • Virus-like Particles (VLP)
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION

  • Research Applications
  • Commercial Applications

GLOBAL VACCINE ADJUVANTS MARKET, BY USAGE TYPE

  • Active Immunostimulants
  • Carriers
  • Vehicle Adjuvants

GLOBAL VACCINE ADJUVANTS MARKET, BY DISEASE AREA

  • Infectious Disease
  • Cancer
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Adjuvants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Adjuvants Market Snippet by Product Type
    • 2.1.2. Vaccine Adjuvants Market Snippet by Application
    • 2.1.3. Vaccine Adjuvants Market Snippet by Usage Type
    • 2.1.4. Vaccine Adjuvants Market Snippet by Disease Area
    • 2.1.5. Vaccine Adjuvants Market Snippet by Country
    • 2.1.6. Vaccine Adjuvants Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Adjuvants Key Market Trends

  • 3.1. Vaccine Adjuvants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Adjuvants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Adjuvants Market Opportunities
  • 3.4. Vaccine Adjuvants Market Future Trends

4. Vaccine Adjuvants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Adjuvants Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Adjuvants Market Landscape

  • 6.1. Vaccine Adjuvants Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Adjuvants Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Mineral Salt-based Adjuvant
    • 7.1.3. Tensoactive Adjuvants
    • 7.1.4. Adjuvant Emulsions
    • 7.1.5. Liposome Adjuvants
    • 7.1.6. Carbohydrate Adjuvants
    • 7.1.7. Bacteria-derived Adjuvants
    • 7.1.8. Virus-like Particles (VLP)
    • 7.1.9. Others

8. Vaccine Adjuvants Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Research Applications
    • 8.1.3. Commercial Applications

9. Vaccine Adjuvants Market - By Usage Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Usage Type, 2022 & 2030 (%)
    • 9.1.2. Active Immunostimulants
    • 9.1.3. Carriers
    • 9.1.4. Vehicle Adjuvants

10. Vaccine Adjuvants Market - By Disease Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Infectious Disease
    • 10.1.3. Cancer
    • 10.1.4. Others

11. Vaccine Adjuvants Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Adjuvants Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Adjuvants Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Adjuvants Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Adjuvants Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Adjuvants Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Vaccine Adjuvants Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Associated British Foods Plc (spi Pharma Inc.)
    • 12.2.2. Adjuvatis
    • 12.2.3. Agenus Inc.
    • 12.2.4. Aphios Corporation
    • 12.2.5. Vertellus
    • 12.2.6. Croda International PLC
    • 12.2.7. CSL Limited
    • 12.2.8. Dynavax Technologies Corporation
    • 12.2.9. GlaxoSmithKline PLC
    • 12.2.10. InvivoGen
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Adjuvants Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Adjuvants Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Adjuvants Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Usage Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Usage Type
  • TABLE Global Vaccine Adjuvants Market, by Usage Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Disease Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Area
  • TABLE Global Vaccine Adjuvants Market, by Disease Area 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Adjuvants Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Adjuvants Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Usage Type segment market share analysis, 2022 & 2030
  • FIGURE Usage Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Area segment market share analysis, 2022 & 2030
  • FIGURE Disease Area segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Europe Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Asia Pacific Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Latin America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Germany Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE India Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Brazil Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Saudi Arabia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)